Use of DPC-4 immunostaining of diagnostic cytology specimens to predict the pattern of tumor progression in locally advanced pancreatic cancer patients (LAPC). Background: The plasma membrane xCT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback